These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 16769812
1. The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling. Scheving LA, Zhang L, Stevenson MC, Kwak ES, Russell WE. Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G16-25. PubMed ID: 16769812 [Abstract] [Full Text] [Related]
2. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. Alimandi M, Wang LM, Bottaro D, Lee CC, Kuo A, Frankel M, Fedi P, Tang C, Lippman M, Pierce JH. EMBO J; 1997 Sep 15; 16(18):5608-17. PubMed ID: 9312020 [Abstract] [Full Text] [Related]
3. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion. Xian W, Rosenberg MP, DiGiovanni J. Oncogene; 1997 Mar 27; 14(12):1435-44. PubMed ID: 9136987 [Abstract] [Full Text] [Related]
4. ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes. Pagano E, Calvo JC. J Cell Biochem; 2003 Oct 15; 90(3):561-72. PubMed ID: 14523990 [Abstract] [Full Text] [Related]
5. EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes. Guren TK, Ødegård J, Abrahamsen H, Thoresen GH, Susa M, Andersson Y, Østby E, Christoffersen T. J Cell Physiol; 2003 Jul 15; 196(1):113-23. PubMed ID: 12767047 [Abstract] [Full Text] [Related]
6. Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes. Dajani OF, Meisdalen K, Guren TK, Aasrum M, Tveteraas IH, Lilleby P, Thoresen GH, Sandnes D, Christoffersen T. J Cell Physiol; 2008 Feb 15; 214(2):371-80. PubMed ID: 17654493 [Abstract] [Full Text] [Related]
7. Epidermal growth factor-induced activation of the insulin-like growth factor I receptor in rat hepatocytes. Hallak H, Moehren G, Tang J, Kaou M, Addas M, Hoek JB, Rubin R. Hepatology; 2002 Dec 15; 36(6):1509-18. PubMed ID: 12447877 [Abstract] [Full Text] [Related]
8. Dexamethasone modulates ErbB tyrosine kinase expression and signaling through multiple and redundant mechanisms in cultured rat hepatocytes. Scheving LA, Buchanan R, Krause MA, Zhang X, Stevenson MC, Russell WE. Am J Physiol Gastrointest Liver Physiol; 2007 Sep 15; 293(3):G552-9. PubMed ID: 17585012 [Abstract] [Full Text] [Related]
9. Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2. Gulliford TJ, Huang GC, Ouyang X, Epstein RJ. Oncogene; 1997 Oct 15; 15(18):2219-23. PubMed ID: 9393980 [Abstract] [Full Text] [Related]
10. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers. Maegawa M, Takeuchi K, Funakoshi E, Kawasaki K, Nishio K, Shimizu N, Ito F. Mol Cancer Res; 2007 Apr 15; 5(4):393-401. PubMed ID: 17426253 [Abstract] [Full Text] [Related]
11. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2. Pedersen NM, Breen K, Rødland MS, Haslekås C, Stang E, Madshus IH. Mol Cancer Res; 2009 Feb 15; 7(2):275-84. PubMed ID: 19208749 [Abstract] [Full Text] [Related]
12. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Huang Y, Li X, Jiang J, Frank SJ. Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991 [Abstract] [Full Text] [Related]
13. Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes. Moriuchi A, Hirono S, Ido A, Ochiai T, Nakama T, Uto H, Hori T, Hayashi K, Tsubouchi H. Biochem Biophys Res Commun; 2001 Jan 12; 280(1):368-73. PubMed ID: 11162525 [Abstract] [Full Text] [Related]
14. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, Di Fiore PP, Kraus MH. Oncogene; 1995 May 04; 10(9):1813-21. PubMed ID: 7538656 [Abstract] [Full Text] [Related]
15. Differential expression of c-fos and c-myc protooncogenes by estrogens, xenobiotics and other growth-stimulatory agents in primary rat hepatocytes. Lee CH, Edwards AM. Arch Toxicol; 2003 Mar 04; 77(3):150-9. PubMed ID: 12632255 [Abstract] [Full Text] [Related]
16. Prolonged EGFR signaling by ERBB2-mediated sequestration at the plasma membrane. Offterdinger M, Bastiaens PI. Traffic; 2008 Jan 04; 9(1):147-55. PubMed ID: 17956594 [Abstract] [Full Text] [Related]
17. Altered regulation of EGF receptor signaling following a partial hepatectomy. Skarpen E, Oksvold MP, Grøsvik H, Widnes C, Huitfeldt HS. J Cell Physiol; 2005 Mar 04; 202(3):707-16. PubMed ID: 15389569 [Abstract] [Full Text] [Related]
18. Effect of EGF on [3H]-thymidine incorporation and cell cycle regulatory proteins in primary cultured chicken hepatocytes: Involvement of Ca2+/PKC and MAPKs. Lee MY, Lee SH, Kim YH, Heo JS, Park SH, Lee JH, Han HJ. J Cell Biochem; 2006 Dec 15; 99(6):1677-87. PubMed ID: 16823772 [Abstract] [Full Text] [Related]
19. Effect of aging on EGF-induced proliferative response in primary cultured periportal and perivenous hepatocytes. Ohtake Y, Maruko A, Ohishi N, Fukumoto M, Ohkubo Y. J Hepatol; 2008 Feb 15; 48(2):246-54. PubMed ID: 18006107 [Abstract] [Full Text] [Related]
20. Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3. Chen X, Yeung TK, Wang Z. Biochem Biophys Res Commun; 2000 Nov 02; 277(3):757-63. PubMed ID: 11062025 [Abstract] [Full Text] [Related] Page: [Next] [New Search]